Other research analysts also recently issued reports about the company. JPMorgan Chase set a €87.70 ($108.27) price target on Gerresheimer and gave the company a buy rating in a report on Thursday, January 4th. Commerzbank set a €77.00 ($95.06) target price on Gerresheimer and gave the stock a buy rating in a research note on Monday, February 5th. DZ Bank reaffirmed a buy rating on shares of Gerresheimer in a research note on Monday, February 26th. Berenberg Bank set a €78.00 ($96.30) target price on Gerresheimer and gave the stock a buy rating in a research note on Friday, March 9th. Finally, Deutsche Bank set a €66.00 ($81.48) target price on Gerresheimer and gave the stock a neutral rating in a research note on Monday, January 22nd. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. Gerresheimer has an average rating of Hold and a consensus price target of €67.96 ($83.90).
Shares of ETR:GXI opened at €66.95 ($82.65) on Monday. Gerresheimer has a 12-month low of €59.97 ($74.04) and a 12-month high of €78.25 ($96.60).
ILLEGAL ACTIVITY NOTICE: “Credit Suisse Group Reiterates €72.00 Price Target for Gerresheimer (GXI)” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.chaffeybreeze.com/2018/04/17/credit-suisse-group-reiterates-72-00-price-target-for-gerresheimer-gxi.html.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.